Osimertinib Responses After Disease Progression in Patients Who Had Been Receiving Rociletinib.

JAMA Oncol 2016 Apr;2(4):541-3

Massachusetts General Hospital Cancer Center, Boston2Harvard Medical School, Boston, Massachusetts.

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.5009DOI Listing
April 2016
14 Reads

Publication Analysis

Top Keywords

patients receiving
4
receiving rociletinib
4
progression patients
4
disease progression
4
osimertinib responses
4
responses disease
4
rociletinib
1
osimertinib
1
disease
1
receiving
1
progression
1
patients
1

Similar Publications